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Abstract 
Saposin B is a lysosomal sphingolipid activator protein which activates GM 1 ganglioside hydrolysis by lysosomal B-galactosidase. To identify the 
structural elements of saposin B implicated in sphingolipid binding, we studied a synthetic peptide corresponding to a predicted a-helix, sapB-18, 
spanning residues 5269 of saposin B. The circular dichroism spectrum of sapB-18 at pH 4.4 was consistent with a 44% a-helix content. As shown 
by intrinsic Tyr fluorescence studies of sapB-18, this peptide binds the GM1 ganglioside with a Kd of about 7flM. Thus, we suggest hat a putative 
amphipathic a-helix between residues 52 and 69 of saposin B plays a major role in the recognition and binding of GM1 ganglioside by saposin B. 
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1. Introduction 
The four saposins are small dimeric glycoproteins, 
with subunit A4,‘s of 8-10 kDa, which activate the hy- 
drolysis of sphingolipids by lysosomal hydrolases [1,2]. 
They have a common precursor, prosaposin, of A4, 70 
kDa [3] containing the saposins as four repeated do- 
mains A, B, C and D [4-71. Saposins A and C are 
/%glucosidase activator proteins [6,8]; saposin B, also 
named the sphingolipid activator protein, is the activator 
of arylsulfatase A, /Sgalactosidase, a-galactosidase [4] 
and neuraminidase [9]; and saposin D is a sphingomyeli- 
nase activator protein [lo]. The physiological function of 
saposin B is apparently to bring together sphingolipids 
and lysosomal enzymes for efficient hydrolysis of hydro- 
phobic lipid substrates [ll]. Both saposin B and 
prosaposin bind a variety of sphingolipids and were 
proposed to be actively involved in intracellular lipid 
transport [12-161. A deficiency in saposin B causes a 
lysosomal storage disease with a clinical presentation 
similar to that of metachromatic leukodystrophy [17]. A 
deficiency in saposin C was described in a single patient 
with a variant form of Gaucher disease [181. No specific 
deficiency in saposin A and D have yet been described 
but two patients with prosaposin deficiency, due to a 
mutation in the initiation codon of the prosaposin gene, 
have been reported [ 191. 
The structure of prosaposin and the saposins are still 
unknown but, in a previous paper, we proposed a struc- 
tural model of saposin B containing an amphipathic 
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a-helix between residues 56 and 65 [20]. In the present 
paper, we use circular dichroism (CD) spectroscopy to 
confirm the helical conformation in solution of a syn- 
thetic peptide, sapB-18, including this region of saposin 
B. Because some amphipathic x-helices have been impli- 
cated in protein-lipid interactions [21-231, we analyzed 
the capacity of sapB-18 to bind to GM1 ganglioside. 
2. Materials and methods 
2. I. Materials 
The peptide sapB-18, NH,-Ser-Gln-Tyr-Ser-Glu-Ile-Ala-Ile-Gln- 
Met-Met-Met-His-Met-Gln-Pro-Lys-Glu-NW,, corresponding to resi- 
dues Ser”-Glu@ of saposin B, was purchased from Multiple Peptide 
Systems, San Diego, CA. It was purified by reverse-phase HPLC and 
analyzed by fast-atom bombardment mass spectrometry. The mass of 
sapB- 18 was 2182 Da, within 1 Da of the mass of the peptide computed 
from monoisotopic elemental composition. GM1 ganglioside was pur- 
chased from Calbiochem, San Diego, CA. 
2.2. CD spectroscopy 
The peptide sapB-18 (91.7 PM in 0.2 M sodium acetate buffer, pH 
4.4) was analyzed by CD spectroscopy at room temperature in a Jobin 
Yvon model CD6 spectrophotometer. The percentage of a-helix was 
computed from the spectrum according to curve-fitting software devel- 
oped in the Department of Biochemistry, University of Cambridge. 
The amphipathic haracter of the putative a-helix (residues 5665) 
of saposin B was determined by computing its mean hydrophobicity per 
residue, <H>, and hydrophobic moment, <p>, according to the 
method of Eisenberg et al. [21]. 
2.3. Fluorescence measurements 
The measurement of intrinsic Tyr’ fluorescence of the sapB- 18 pep- 
tide was used to study GM1 ganglioside binding in a Perkin-Elmer 
model LS 30 spectrofluorometer atan excitation wavelength of 280 nm. 
The fluorescence spectrum of 5 PM sapB-18 was recorded in the pres- 
ence of increasing concentrations of GM1 ganglioside between 0.625 
and 12.5 PM. The spectra were corrected for the fluorescence associated 
to GM1 ganglioside itself. GM1 ganglioside was dissolved in chloro- 
form: methanol (2: 1) and the solvent was evaporated under 
a stream of nitrogen. The lipid was resuspended in0.2 M sodium acetate 
buffer, pH 4.4, and sonicated for 6 s with an ARTEK sonicator at 60% 
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of maximum intensity. The peptide-lipid mixture was incubated for IO 
min at 20°C before recording the fluorescence spectrum. 
The lipid-peptide interaction was analyzed by means of a Scatchard 
plot to determine the number of lipid (L) binding sites per mol of 
peptide (P), n, and the equilibrium dissociation constant, &, of the 
complex. 
P+L PL 
I, is the fluorescence intensity of the free peptide and I, is the fluores- 
cence intensity of peptide in presence of the GM1 ganglioside ligand. 
3. Results and discussion 
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Fig. I. Circular dichroism spectrum of the synthetic peptide sapB-I 8. 
The predicted a-helix of saposin B (between residues 
G1uS6 and Met65) is an amphipathic helix with a mean 
hydrophobicity per residue <H> of 0.40 and a hydro- 
phobic moment <,un> of 0.28. It has an amphipathic 
character between that of a transmembrane and a globu- 
lar protein a-helix in the classification of Eisenberg et al. 
[21]. Thus, this putative a-helix is a good candidate sub- 
domain of saposin B for interaction with sphingolipids. 
Saposin B binds to GM1 ganglioside [4,11]. We have 
hypothesized that the putative amphipathic a-helix be- 
tween residues 56 and 65 of saposin B may be implicated 
in this binding function [20]. To test this hypothesis, the 
peptide sapB-18, NH,-Ser-Gln-Tyr-Ser-Glu-Ile-Ala-Ile- 
Gln-Met-Met-Met-His-Met-Gln-Pro-Lys-Glu-NH,, cor- 
responding to the sequence Ser52-G1u69 of saposin B, was 
synthesized. The CD spectrum of sapB-18 is compatible 
with a 44% a-helix content with typical minima at 208 
and 220 nm (Fig. 1). However, it must be pointed out 
that in the complete saposin B structure, this peptide may 
adopt a different conformation. 
The peptide-lipid interaction was studied by measur- 
ing Tyr’ fluorescence of the sapB-18 peptide as a func- 
tion of increasing GM1 ganglioside concentration. De- 
termination of the binding constant using a Scatchard 
plot according to Eq. 2 yielded a Kd value of 7.0 k 2.1 
PM and a n-value of 0.82 + 0.25 (mean k S.D. of 3 deter- 
minations) (Fig. 2). This result suggests that there is only 
one GM 1 ganghoside binding site per sapB- 18 peptide 
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Fig. 2. Scatchard analysis of GMI ganglioside binding to the synthetic 
peptide sapB-IX. 
molecule. The binding constant of GM 1 ganglioside for 
sapB-18 is close to that determined for purified saposin 
B (around 12 ,uM) by Hiraiwa et al. [15]. This result 
suggests that the sapB-18 peptide plays a role in sphin- 
golipid binding and recognition but does not exclude the 
participation of other structural elements of saposin B. 
As a control experiment, an 1 R-residue synthetic peptide 
of saposin C, derived from the same region as sapB- 18 
was from saposin B (Fig. 3) did not bind GM1 gangli- 
oside (data not shown). 
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Fig. 3. Alignment of saposins A, B. C and D amino acid sequences [4] indicating the synthetic peptides sapB-I8 and sapC-I8 sequences, 
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Patthy reported that saposin B is similar to the surfac- 
tant protein B (SP-B), another lipid-binding protein [22]. 
This protein is a major component of the lung surfactant 
together with other lipid-binding proteins and phosphol- 
ipids. It is interesting to note that a synthetic peptide 
(Leu4”pLeu66 of SP-B), corresponding approximately to 
the position of sapB-18 in saposin B, also adopts an 
a-helical conformation and binds lipids [23]. This simi- 
larity between SP-B and saposin B suggests that these 
two similar proteins may bind lipids using similar struc- 
tural elements and mechanisms. 
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